HUTCHMED DRC

Healthcare · Drug Manufacturers - Specialty & Generic

14.30$ +0.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

HUTCHMED DRC (HCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,736 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Balance Sheet HCM
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	342	342	345	345	598	598	578	578	532	532	539	495	454	465	465	526	724	724	693	1,273	1,373	1,373	1,194	1,194	1,029	1,029	1,297	1,297	1,280	1,280	1,261	1,261	1,274	1,274	1,776	1,776	1,753	1,753	1,736	1,736
Current Assets	167	167	178	178	432	432	358	395	371	371	350	309	277	317	220	375	531	531	496	1,091	1,212	1,212	1,022	1,022	840	840	1,090	1,090	1,097	1,097	1,048	1,048	1,067	1,067	1,592	1,592	1,567	1,567	1,553	1,553
Cash	79	79	113	113	85	85	-358	75	86	86	92	83	97	121	-220	50	236	236	346	587	378	378	468	468	313	313	223	223	284	284	204	204	154	154	111	111	71	71	107	107
Cash & Short-Term Investments	105	104	114	113	358	358	358	322	–	301	272	237	202	217	220	281	439	435	396	950	1,014	1,012	830	826	633	631	858	856	889	886	804	804	839	836	1,366	1,366	1,369	1,367	1,376	1,376
Receivables	46	46	46	50	42	42	55	47	57	43	42	43	40	41	78	46	48	48	53	58	84	148	77	77	98	98	129	129	117	117	157	157	156	168	147	147	127	148	118	118
Inventory	13	13	11	11	12	12	9.8	9.8	12	12	18	14	16	16	15	15	20	20	20	26	36	36	46	46	57	57	54	54	50	50	46	46	50	50	48	48	41	41	41	41
Property, Plant & Equipment	10.0	10.0	12	12	14	15	14	14	17	18	22	24	25	26	26	26	32	32	36	39	53	53	44	44	85	85	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	3.1	3.1	–	3.3	3.3	3.3	–	3.4	3.2	3.2	–	–	–	3.1	–	–	3.3	3.3	–	–	–	3.4	–	–	–	3.1	–	–	–	3.1	–	–	–	3.0	–	–	3.1	3.1	–	–
Intangible Assets	0.5	0.5	–	0.4	0.4	0.4	–	5.0	0.3	0.3	–	–	–	0.3	–	–	0.2	0.2	–	–	–	0.2	–	–	–	–	–	–	–	600	–	–	–	–	–	–	–	8.9	–	–
Total Liabilities	138	138	133	133	113	113	-485	120	120	120	139	122	116	152	-313	159	205	205	229	259	333	333	342	342	393	393	497	497	536	536	509	509	502	502	534	534	502	502	461	461
Current Liabilities	95	95	97	97	105	105	85	85	85	85	101	111	105	113	119	119	158	158	189	248	312	312	322	322	354	354	341	341	403	403	373	373	377	377	342	342	316	316	275	275
Short-Term Debt	22	22	30	30	32	32	1.6	1.6	–	0.4	3.2	3.5	3.5	85	–	2.6	2.8	6.0	4.0	31	32	32	–	–	3.7	3.7	–	-52	35	35	29	29	26	26	30	30	28	28	22	22
Accounts Payable	36	36	33	33	24	24	19	19	26	26	31	26	23	24	26	26	32	32	29	29	41	41	51	51	71	71	55	55	36	36	43	43	43	43	44	44	46	46	34	34
Long-Term Debt	35	29	28	20	0.6	0.6	27	27	27	27	27	0.0	0.6	27	–	27	–	27	27	0.0	–	–	–	0.4	–	18	–	40	–	48	–	56	–	59	–	93	–	68	–	–
Shareholders' Equity	184	184	189	189	462	462	485	432	389	389	376	348	314	288	313	342	484	484	428	985	987	987	800	800	610	610	782	782	731	731	740	740	760	760	1,229	1,229	1,238	1,238	1,261	1,261
Retained Earnings	-80	-80	-79	-79	-107	-107	-141	-141	-183	-183	-204	-229	-260	-290	-340	-340	-416	-416	-457	-518	-610	-610	-773	-773	-971	-971	-803	-803	-871	-871	-845	-845	-833	-833	-380	-380	-379	-379	-363	-363
Shares Outstanding	122	122	122	122	126	126	133	664	133	133	133	133	133	666	137	27	142	145	29	29	171	171	170	170	169	169	173	173	170	170	175	175	175	175	175	175	175	175	175	175

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings